Neural crest-associated gene FOXD1 induces an immunosuppressive microenvironment by regulating myeloid-derived suppressor cells in melanoma
Journal for ImmunoTherapy of Cancer · 2025
DOI: 10.1136/jitc-2024-010352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2025. Verfasst von Qian Sun und 16 weiteren Autor:innen. Beteiligte Einrichtung: Skin Cancer Unit, German Cancer Research Center (DKFZ) and DKFZ Hector Cancer Institute, Heidelberg, Baden-Württemberg, Germany. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Melanoma, Forkhead Transcription Factors, Tumor Microenvironment. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background
Neural crest-associated genes play pivotal roles in tumor initiation, progression, and the intricate dynamics of the tumor microenvironment (TME). Myeloid-derived suppressor cells (MDSC) within the TME are important in dampening T cell activity and contributing to resistance against immunotherapeutic interventions. The neural crest-associated gene Forkhead Box D1 (FOXD1) has been identified as an oncogenic factor that induces melanoma dedifferentiation and progression. However, the underlying mechanisms and the impact of FOXD1 on the antitumor immune response remain unclear.
Methods
To investigate the impacts of FOXD1 on the melanoma microenvironment, we analyzed publicly available datasets from multiple platforms, including TNMplot, TIMER2.0, etc. In addition, FOXD1 was overexpressed (OE) or knocked down in melanoma cells to identify its biological functions in vitro and in vivo. Flow cytometry and arginase activity assay were used to analyze the phenotype and function of MDSC. Western blot, reverse transcription-PCR, or ELISA assays were employed to analyze the expression of FOXD1 and its downstream effectors. In vivo experiments were conducted to investigate the role of FOXD1 in melanoma progression and the influence on MDSC accumulation within the TME.
Results
We demonstrate that increased FOXD1 levels inversely correlated with melanoma responsiveness to immunotherapy. Ex-vivo analyses unveiled that monocytes, exposed to conditioned medium from FOXD1-OE melanoma cells, effectively suppressed T cell proliferation and upregulated the expression of programmed death-ligand 1 (PD-L1) and other immunosuppressive factors. FOXD1 was identified as a direct regulator of interleukin 6 (IL6) expression, which is pivotal for MDSC induction. Blocking IL6 reversed MDSC-associated immunosuppression. Additionally, miR-581, a potential negative regulator of FOXD1, attenuated the impact of FOXD1 on IL6 expression and MDSC differentiation. In vivo experiments demonstrated that tumors derived from FOXD1 OE melanoma cells contained a significantly higher frequency of PD-L1 + MDSC compared with controls, while FOXD1 knockdown resulted in reduced tumor growth and diminished MDSC accumulation.
Conclusion
Our study elucidated a novel function of FOXD1 in melanoma pathogenesis, highlighting its role in orchestrating the immunosuppressive TME by promoting the generation of MDSC via IL6 upregulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Skin Cancer Unit, German Cancer Research Center (DKFZ) and DKFZ Hector Cancer Institute, Heidelberg, Baden-Württemberg, Germany.
- Department of Dermatology Venereology and Allergology, Heidelberg University, Mannheim, Baden-Württemberg, Germany.
- Department of Otorhinolaryngology, Head and Neck Surgery, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.
- State Key Laboratory of Molecular Oncology, Tsinghua university, School of Basic Medical Sciences, Beijing, China.
- Peking University Institute of Systems Biomedicine, Beijing, China.
- Skin Cancer Unit, German Cancer Research Center (DKFZ) and DKFZ Hector Cancer Institute, Heidelberg, Baden-Württemberg, Germany j.utikal@dkfz.de v.umansky@dkfz-heidelberg.de.
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Sun, Q., Wang, N., Poelchen, J., Peter, M., Novak, D., Özbay Kurt, F. G., Bitsch, R., Wu, H., Wang, Y., Pardo, S., Han, R., Liu, S., Gong, L., Zhang, Y., Wistuba-Hamprecht, K., Umansky, V., & Utikal, J. S. (2025). Neural crest-associated gene FOXD1 induces an immunosuppressive microenvironment by regulating myeloid-derived suppressor cells in melanoma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2024-010352
Vancouver
Sun Q, Wang N, Poelchen J, Peter M, Novak D, Özbay Kurt FG, et al. Neural crest-associated gene FOXD1 induces an immunosuppressive microenvironment by regulating myeloid-derived suppressor cells in melanoma. Journal for ImmunoTherapy of Cancer. 2025. doi:10.1136/jitc-2024-010352
BibTeX
@article{Sun2025,
author = {Sun, Qian and Wang, Nina and Poelchen, Juliane and Peter, Mareike and Novak, Daniel and Özbay Kurt, Feyza Gül and Bitsch, Rebekka and Wu, Huizi and Wang, Yiman and Pardo, Sandra and Han, Rui and Liu, Shibo and Gong, Lidong and Zhang, Yuxin and Wistuba-Hamprecht, Kilian and Umansky, Viktor and Utikal, Jochen Sven},
title = {Neural crest-associated gene FOXD1 induces an immunosuppressive microenvironment by regulating myeloid-derived suppressor cells in melanoma},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2025},
doi = {10.1136/jitc-2024-010352}
}
EUVIMED